Perfluorinated Compounds (PFAS) vs Cyclopentasiloxane: which is worse?
Quick answer: Perfluorinated Compounds (PFAS) carries the heavier risk profile. Perfluorinated Compounds (PFAS) is — in the EU and — in the US; Cyclopentasiloxane is restricted in the EU and allowed in the US.
| Property | Perfluorinated Compounds (PFAS) | Cyclopentasiloxane |
|---|---|---|
| EU status | — | Restricted |
| US status | — | Allowed |
| Risk level | — | medium |
| Banned in | European Union (broadly restricting PFAS in food contact materials since 2020; EU-wide PFAS restriction proposal under REACH), Denmark (banned PFAS in all food packaging 2020) | — |
| Restricted in | United States (EPA has set maximum contaminant levels for 6 PFAS in drinking water in 2024; FDA has been working with industry to phase out certain PFAS from food packaging) | European Union |
| Category | additive | endocrine disruptor |
| Where it hides | — | hair serum, primer, deodorant |
What is Perfluorinated Compounds (PFAS)?
Per- and polyfluoroalkyl substances (PFAS) are a large family of synthetic chemicals characterized by extremely strong carbon-fluorine bonds. They are used in food packaging (grease-resistant coatings), non-stick cookware (PTFE/Teflon), food processing equipment, firefighting foam, and many industrial applications. The 'forever chemicals' moniker reflects their extreme environmental persistence.
What is Cyclopentasiloxane?
Cyclopentasiloxane is a volatile silicone (D5) used for smooth, silky texture.
Documented risks
Perfluorinated Compounds (PFAS): PFAS are among the most extensively studied and harmful groups of synthetic chemicals in the modern environment. Their unique carbon-fluorine bond stability means they do not break down in the environment or in human body tissues — contributing to bioaccumulation over a lifetime. Health effects documented in human epidemiological studies include: - Cancer: PFOA (perfluorooctanoic acid) and PFOS (perfluorooctanesulfonic acid) have been associated with kidney cancer, testicular cancer, thyroid cancer, bladder cancer, and non-Hodgkin lymphoma in occupationally exposed workers and community members with contaminated drinking water. IARC classified PFOA as Group 1 (human carcinogen) in 2023 and PFOS as Group 2B. - Endocrine disruption: PFAS disrupt thyroid hormone signaling and sex hormone balance. Multiple studies find associations between PFAS exposure and hypothyroidism, early puberty in girls, and reduced sperm quality. - Immune suppression: studies have found that PFAS exposure is associated with reduced vaccine response in children and adults, suggesting PFAS may impair immune function. - Developmental effects: prenatal PFAS exposure has been associated with lower birth weight, developmental delays, and reduced immune response in infants. - Cholesterol: PFAS exposure consistently raises LDL cholesterol levels, increasing cardiovascular disease risk. The 2023 EPA MCLG (maximum contaminant level goal) for PFOA and PFOS is zero — reflecting the agency's conclusion that there is no safe level. The EPA set enforceable MCLs in drinking water in 2024. The DuPont/3M PFOA/PFOS contamination of drinking water in communities near Teflon manufacturing facilities led to a $671 million settlement (DuPont/Chemours, 2017) and $10.3 billion 3M settlement (2023) — among the largest environmental contamination settlements in history.
Cyclopentasiloxane: Persistent and bioaccumulative; the EU restricts D5 in wash-off products over environmental and endocrine concerns. The US has no restriction.
Scan a barcode and we'll flag both Perfluorinated Compounds (PFAS) and Cyclopentasiloxane (plus 200+ other ingredients banned overseas).
Scan free →